Welcome to our dedicated page for Axt news (Ticker: AXTI), a resource for investors and traders seeking the latest updates and insights on Axt stock.
AXT, Inc. (AXTI) is a material science company that develops and manufactures high-performance compound and single element semiconductor substrate wafers, with a focus on indium phosphide, gallium arsenide and germanium. The company’s news flow reflects its role in supplying specialty substrates for applications such as 5G infrastructure, data center connectivity using silicon photonics, passive optical networks, LED lighting, lasers, sensors, power amplifiers for wireless devices and satellite solar cells.
News about AXT often centers on quarterly financial results, where the company reports revenue, margins and net income or loss, along with management commentary on demand trends for its substrates. Investors can follow updates on how export control permits in China affect shipments of indium phosphide and gallium arsenide products and how these factors influence reported revenue in specific periods.
AXT also issues press releases about capital markets activity, including underwritten public offerings of common stock under its shelf registration statement on Form S-3. These announcements describe intended uses of proceeds, such as expanding manufacturing capacity at its subsidiary Beijing Tongmei Xtal Technology Co., Ltd., supporting research and development of new or improved products and funding general corporate and working capital needs.
Additional AXTI news items include participation in investor conferences, preliminary revenue ranges ahead of earnings releases, updates on the proposed STAR Market listing of its Tongmei subsidiary, and corporate governance developments such as board changes and Nasdaq listing rule compliance matters. For investors tracking AXTI stock, this news page provides a centralized view of company press releases and related disclosures that describe operational performance, regulatory developments and strategic priorities.
AXT (Nasdaq: AXTI) updated its Q4 2025 revenue outlook to $22.5–$23.5 million, citing fewer export permits for indium phosphide issued by China’s Ministry of Commerce that limited December shipments. The company said customer demand remains strong and expects additional permits in Q1 2026. AXT completed a capital raise in December and plans to use proceeds to expand manufacturing capacity, targeting more than double indium phosphide capacity in the second half of 2026 to support AI and optical connectivity demand.
AXT will release Q4 2025 results and host an earnings call on Feb 19, 2026 at 1:30 p.m. PT; replay available through Feb 26, 2026.
AXT (Nasdaq: AXTI) closed an underwritten public offering of 8,163,265 shares of common stock at $12.25 per share on December 30, 2025, including full exercise of the underwriters’ option to purchase an additional 1,064,773 shares.
The company received approximately $100 million gross proceeds before underwriting discounts, and intends to use net proceeds primarily to increase manufacturing capacity at its Beijing Tongmei Xtal subsidiary to produce indium phosphide substrates for export, for research and development, and for general corporate and working capital purposes.
Northland Capital Markets acted as sole bookrunner; Wedbush and Craig-Hallum served as co-managers. The offering was made under an S-3 shelf registration effective November 27, 2025.
AXT (Nasdaq: AXTI) priced an underwritten public offering of 7,098,492 shares at $12.25 per share, generating gross proceeds of approximately $87.0 million. The company granted a 30‑day overallotment option for up to 1,064,773 additional shares, which if fully exercised would raise aggregate gross proceeds to about $100 million. The offering is expected to close on or about December 30, 2025, subject to customary conditions. Net proceeds are intended primarily to expand manufacturing capacity at Beijing Tongmei Xtal to produce indium phosphide substrates for export, and for R&D and general corporate and working capital purposes. Northland Capital Markets is sole bookrunner; Wedbush and Craig‑Hallum are co‑managers.
AXT (NasdaqGS: AXTI) will participate in the Northland Securities Growth Conference on Tuesday, Dec. 16, 2025. The company, a manufacturer of compound semiconductor substrates based in Fremont, Calif., said the conference will be a virtual event.
Investors can expect a company presentation and management availability during the virtual session on that date.
AXT (Nasdaq: AXTI) reported Q3 2025 results for the quarter ended September 30, 2025. Revenue was $28.0 million, up from $18.0 million in Q2 2025 and $23.6 million in Q3 2024. The company said indium phosphide revenues rose more than 250% sequentially as export permits enabled significant orders and backlog growth.
GAAP gross margin was 22.3% in Q3 2025 (non‑GAAP 22.4%). GAAP net loss was $1.9 million, $0.04 per share; non‑GAAP net loss was $1.2 million, $0.03 per share, both improved from Q2 2025.
The company noted ongoing backlog for indium phosphide and gallium arsenide, reiterated margin recovery efforts, provided a STAR Market IPO update for its Tongmei unit (pending CSRC approval), and scheduled a conference call on October 30, 2025 at 1:30 p.m. PT.
AXT (Nasdaq: AXTI) will release its third quarter 2025 financial results after market close on October 30, 2025. The company will host a conference call the same day at 1:30 p.m. PT to discuss results, accessible by phone at (800) 715-9871 with passcode 4378083 or via a live webcast at www.axt.com. A replay will be available by phone at (800) 770-2030 (same passcode) through November 6, 2025. Additional investor materials are available at http://www.axt.com.
AXT Inc (NASDAQ:AXTI), a compound semiconductor wafer substrates manufacturer, reported Q2 2025 financial results with revenue of $18.0 million, down from $19.4 million in Q1 2025 and $27.9 million in Q2 2024. The company posted a GAAP net loss of $7.0 million, or $0.16 per share.
The quarter saw improved GAAP gross margin of 8.0%, up from -6.4% in Q1 2025, though down from 27.4% in Q2 2024. The company faced challenges with longer gallium arsenide export permit processing times and sluggish demand in China. However, AXT experienced growth in AI-related demand for indium phosphide in China and began shipping indium phosphide substrates internationally after receiving initial export permits in June.
AXT Inc (NASDAQ:AXTI), a compound semiconductor substrate manufacturer, announced the passing of board member Christine Russell on July 11, 2025. Russell, who joined the board in December 2019 as an independent director, served as Chair of the Audit Committee and was a member of both the Compensation Committee and Nominating and Corporate Governance Committee.
CEO Morris Young acknowledged Russell's contributions, highlighting her intelligence, strategic planning abilities, and thoughtful decision-making approach during her tenure on the board.
AXT Inc (NASDAQ:AXTI), a compound semiconductor substrate manufacturer, has announced preliminary Q2 2025 revenue expectations of $17.5-18 million, falling below their previous guidance of $20-22 million. The revenue shortfall is attributed to slower export control permit issuance for gallium arsenide products and weakened demand in China.
Despite challenges, the company reports a significant increase in AI-related demand for indium phosphide in China during Q2. Their subsidiary, Tongmei, received its first export control permits for indium phosphide late in the quarter. Management expects Q2 2025 gross margins in the high single digits. The full financial results will be announced on July 31, 2025.